New Injectable
Recently, the Food and Drug Administration (FDA) authorised dumilumab (Dupixent), a new injectable antibody. This new medication is used to treat diseases that are resistant to other treatments. Despite the lack of sufficient research on its effectiveness in assisting humans, it has been shown to be secure for use.
